Holen Sie sich die Stockscreener-App
297.17
7.75%
21.37
Handel nachbörslich:
296.94
-0.23
-0.08%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$275.80
Offen:
$287
24-Stunden-Volumen:
14.64M
Relative Volume:
1.44
Marktkapitalisierung:
$371.63B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
56.09
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
+19.47%
1M Leistung:
+34.68%
6M Leistung:
+83.22%
1J Leistung:
+306.19%
1-Tages-Spanne:
$285.85
$297.87
1-Wochen-Bereich:
$248.66
$297.87
52-Wochen-Spanne:
$72.91
$297.87
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
297.17 | 344.91B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,544.74 | 556.13B | 39.08B | 11.61B | 9.94B | 30.00 |
AMAT
Applied Materials Inc
|
428.62 | 326.03B | 28.21B | 7.84B | 6.19B | 9.7629 |
KLAC
Kla Corp
|
1,816.29 | 226.36B | 13.09B | 4.67B | 4.01B | 35.37 |
TER
Teradyne Inc
|
382.48 | 55.90B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Why is Lam Research stock hitting a new all-time high today? - Investing.com Canada
Lam Research Corporation (NASDAQ:LRCX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Why is Lam Research stock surging today? - Investing.com
Why is Lam Research stock surging today? By Investing.com - Investing.com Canada
Lam Research Stock Hits Fresh High as AI Chip Demand Meets China Risk - TechStock²
Lam Research: $140B WFE, $725B In Hyperscaler Capex, And Still Raising — BUY (NASDAQ:LRCX) - Seeking Alpha
Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand - Quiver Quantitative
Lam Research stock hits all-time high at 275.99 USD By Investing.com - Investing.com Canada
Lam Research stock hits all-time high at 275.99 USD - Investing.com
Lam Research Corp Stock (LRCX) Opened Up by 4.00% on May 5: A Full Analysis - TradingKey
Lam Research Is Approaching Frothy Levels (NASDAQ:LRCX) - Seeking Alpha
Lam Research (LRCX): The Top AI Stock with Potential to Rise 1000 Percent - Insider Monkey
Lam Research perks up as Q3 results, guidance top estimates - MSN
Why the VanEck Semiconductor ETF Rallied Over 30% in April - The Motley Fool
LAM RESEARCH CORP (NASDAQ:LRCX) Near a Breakout with Perfect Technical Setup and Strong Growth Fundamentals - ChartMill
M&T Bank Corp Boosts Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research SVP Neil Fernandes sells $4.6m in company stock - Investing.com Nigeria
LAM Research (LRCX) SVP Neil Fernandes sells 18,170 shares under 10b5-1 plan - Stock Titan
Varma Mutual Pension Insurance Co Cuts Position in Lam Research Corporation $LRCX - MarketBeat
Truist Financial Corp Purchases 115,339 Shares of Lam Research Corporation $LRCX - MarketBeat
Raiffeisen Bank International AG's Lam Research Corp(LRCX) Holding History - GuruFocus
Montag A & Associates Inc. Sells 22,466 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research, Applied Materials among market cap stock movers on Thursday - Investing.com
Lam Research Corporation $LRCX Shares Sold by Strs Ohio - MarketBeat
Horizon Investments LLC Has $20.52 Million Stake in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by Sigma Planning Corp - MarketBeat
Caisse Des Depots ET Consignations Sells 6,461 Shares of Lam Research Corporation $LRCX - MarketBeat
Artemis Investment Management LLP Has $88.35 Million Position in Lam Research Corporation $LRCX - MarketBeat
Systematic Growth Fund's Lam Research Corp(LRCX) Holding History - GuruFocus
Harber Asset Management LLC's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research (LRCX) proposed sale: 18,170 shares via Fidelity (NASDAQ) - Stock Titan
Putnam Dynamic Asset Allocation Growth Fund's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research Corporation $LRCX Shares Sold by US Bancorp DE - MarketBeat
Lam Research Corporation $LRCX Shares Sold by Danske Bank A S - MarketBeat
LRCX Stock Price, Quote & Chart | LAM RESEARCH CORP (NASDAQ:LRCX) - ChartMill
Lam Research (NASDAQ:LRCX) Stock Price Up 3.7%What's Next? - MarketBeat
Lam Research Corp (LRCX) Stock Up 3.7% but GF Value Says Overval - GuruFocus
Musk’s Terafab taps Applied Materials, Tokyo Electron, Lam Research in chip push: report - MSN
Lam Research Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Vanguard Capital Management (LRCX) files Schedule 13G showing 7.49% ownership - Stock Titan
Jennison Associates LLC Acquires 53,347 Shares of Lam Research Corporation $LRCX - MarketBeat
State of New Jersey Common Pension Fund D Sells 17,989 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation (LRCX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Erste Group Bank Weighs in on Lam Research FY2027 Earnings - MarketBeat
Lam Research Corp (NASDAQ:LRCX) Shines as a Quality Investment in Caviar Cruise Screen - ChartMill
Analyst Upgrades PT on Lam Research After Q3 Earnings, What’s Next? - Insider Monkey
The Zacks Analyst Blog Highlights Lam Research, BlackRock, Corning, Monarch Cement and BK Technologies - Yahoo Finance
Polen Focus Growth Bets on Lam Research (LRCX), a Critical Supplier of Etch and Deposition Equipment - Yahoo Finance
Brentview Investment Management LLC's Lam Research Corp(LRCX) Holding History - GuruFocus
GC Wealth Management RIA LLC Reduces Stock Position in Lam Research Corporation $LRCX - MarketBeat
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):